A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024

Researchers link cancer gene to Scottish island

byUniversity of EdinburghGrandparental ancestry of BRCA2 c.517-2A>G carriers in VIKING I. Credit:European Journal of Human Genetics(2024). DOI: 10.1038/s41431-024-01704-wPeople wi

Updated on: November 08,2024

Researchers link cancer gene to Scottish island

byUniversity of EdinburghGrandparental ancestry of BRCA2 c.517-2A>G carriers in VIKING I. Credit:European Journal of Human Genetics(2024). DOI: 10.1038/s41431-024-01704-wPeople wi

Updated on:November 08,2024

Novel technique reveals surprising way to suppress tumor cells

by Alan Dove,Cornell UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111412By analyzing key enzymes in a new way, an international team led by res

Updated on: January 13,2024

Novel technique reveals surprising way to suppress tumor cells

by Alan Dove,Cornell UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111412By analyzing key enzymes in a new way, an international team led by res

Updated on:January 13,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on: September 30,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on:September 30,2024

Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAn accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstructi

Updated on: October 22,2024

Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAn accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstructi

Updated on:October 22,2024

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Updated on: January 23,2024

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Updated on:January 23,2024

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainNew findings from researchers in the Perelman School of Medicine at the University of Pennsy

Updated on: June 01,2024

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainNew findings from researchers in the Perelman School of Medicine at the University of Pennsy

Updated on:June 01,2024

'Magic bullet' takes aim at pancreatic cancer

by University of South AustraliaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainEvery day, more than 1200 people worldwide are told they

Updated on: March 14,2024

'Magic bullet' takes aim at pancreatic cancer

by University of South AustraliaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainEvery day, more than 1200 people worldwide are told they

Updated on:March 14,2024

Consumer health: Understanding metastatic brain cancer

by Laurel KellyCredit: Unsplash/CC0 Public DomainMay is Brain Cancer Awareness Month, which makes this a good time to learn about metastatic brain cancer.Overall, the chance that a person will develop

Updated on: January 11,2024

Consumer health: Understanding metastatic brain cancer

by Laurel KellyCredit: Unsplash/CC0 Public DomainMay is Brain Cancer Awareness Month, which makes this a good time to learn about metastatic brain cancer.Overall, the chance that a person will develop

Updated on:January 11,2024

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea

Updated on: May 20,2024

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea

Updated on:May 20,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on: September 27,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on:September 27,2024

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Updated on: May 21,2024

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Updated on:May 21,2024